✨ 14 results found - Searched 22063 records in 3ms.
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_profil-imunofenotip-mutasi-gen-flt3-itd-npm1-dan-cebpa-pada-leukemi-20221205104157.jpg&width=120)
Disertasi
PROFIL IMUNOFENOTIP, MUTASI GEN FLT3-ITD, NPM1, DAN CEBPA PADA LEUKEMIA MIELOID AKUT, SERTA HUBUNGANNYA DENGAN LUARAN KLINIS.
2015 | BY Abdul Muthalib - Siti Boedina Kresno - Agus Susanto Kosasih - Rahayuningsih Setiabudy- THE PROFILE OF IMMUNOPHENOTYPE, FLT3-ITD, NPM1 AND CEBPA GENE MUTATION IN ACUTE MYELOID LEUKEMIA AND ITS RELANTIONSHIP WITH CLINICAL OUTCOME.
- Nomor Panggil D15031fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_peran-mir-10b-mir-21-supar-dan-pai-1-sebagai-prediktor-respons-terap-20221128102858.jpg&width=120)
Disertasi
Peran MiR-10b, MiR-21, SuPAR dan PAI-1 Sebagai Prediktor Respons Terapi dan Progresivitas pada Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK).
2017 | BY Lyana Setiawan - Noorwati Sutandyo - Siti Boedina Kresno - Rahajuningsih Setiabudy- The Role of MiR-10b, MiR-21, Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), and Plasminogen Activator Inhibitor (PAI)-1 as Predictors of Treatment Response and Progressivity in Non-Small Cell Lung Cancer (NSCLC).
- Nomor Panggil D17020fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_luaran-terapi-dan-faktor-prognostik-pasien-kanker-serviks-ivb-outco-20230801142851.jpg&width=120)
Tesis
Luaran Terapi dan Faktor Prognostik Pasien Kanker Serviks IVB
2023 | BY Rainey Ahmad Fajri Putranta - Irwan Ramli - Arie Munandar - Muchtaruddin Mansyur - Ayu Santika Santaningrum- Outcome and Prognostic Factor for Cervical Cancer stage IVB Patients.
- Nomor Panggil T23211fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_analisis-terapi-afatinib-pada-adenokarsinoma-paru-dengan-mutasi-epider-20230801081730.jpg&width=120)
Tesis
Analisis terapi afatinib pada adenokarsinoma paru dengan mutasi epidermal growth factor receptor (EGFR) di RSUP Persahabatan
2023 | BY Widya Angasreni - Sita Laksmi Andarini - Jamal Zaini- Therapy Analysis of afatinib in lung adenocarcinoma with epidermal growth factor receptor mutation (EGFR) at Persahabatan Hospital.
- Nomor Panggil T23185fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_overall-survival-dan-disease-free-survival-kanker-serviks-sel-skuamosa-20231128143808.jpg&width=120)
Tesis
Overall survival dan Disease Free Survival kanker serviks sel skuamosa vs adenokarsinoma stadium lanjut dikaitkan dengan respon radiasi
2019 | BY Ivolay Walasi Margret Dachi - ANDRIJONO- Overall survival and disease free survival of squamous cell carcinoma vs. adenocarcinoma advanced stage cervical carcinoma assosiated radiation response.
- Nomor Panggil T19495fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_profil-pasien-kanker-rektum-yang-menjalani-radiasi-di-departemen-radio-20231019101256.jpg&width=120)
Tesis
Profil Pasien Kanker Rektum yang Menjalani Radiasi di Departemen Radioterapi RSUPN Cipto Mangunkusumo Periode Tahun 2009 – 2014
2015 | BY Annisa Febi Indarti - Sri Mutya Sekarutami - Sahat Matondang- Profile of Rectal Cancer Patients Underwent Radiation Therapy in Department of Radiotherapy, National General Hospital of Cipto Mangunkusumo during Period of 2009 – 2014.
- Nomor Panggil T 15 302 FK
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_profil-pasien-glioma-yang-menjalani-radiasi-di-rsupn-dr-cipto-mangunk-20231018092020.jpeg&width=120)
Tesis
Profil Pasien Glioma yang Menjalani Radiasi di RSUPN Dr. Cipto Mangunkusumo Tahun 2009-2014
2015 | BY Rika Ruhama - Sri Mutya Sekarutami - Rahmad Mulyadi- The Profile Of Glioma Patients Underwent Radiation Therapy In Cipto Mangunkusumo National Hospital Period 2009-2014.
- Nomor Panggil T 15 260 FK
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_efikasi-dan-toksisiti-kemoterapi-karboplatin-vinorelbin-pada-pasien-ka-20231204102717.jpg&width=120)
Tesis
Efikasi Dan Toksisiti Kemoterapi Karboplatin-Vinorelbin Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut DI RSUP Persahabatan
2017 | BY Sita Laksmi Andarini - Jamal Zaini - Putu Ayu Diah Puspita Sari- Efficacy and Toxicity of Carboplatin-Vinorelbine Chemotherapy in advanced Non-small cell lung cancer (NSCLC) Patients at Persahabatan Hospital.
- Nomor Panggil T17357fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2FTESIS.jpg.jpg&width=120)
Tesis
Efektivitas dan Keamanan Sorafenib Dosis Inisiasi 400 mg Dibandingkan Sorafenib Dosis Inisiasi 800 mg terhadap Kesintasan Pasien Karsinoma Sel Hati Stadium Lanjut dan Intermediet: Suatu Telaah Sistematis dan Meta-analisis
2021 | BY Roland Helmizar - Juferdy Kurniawan - Alvina Widhani - Rudi Putranto- Effectiveness and Safety of Sorafenib 400 mg Initial Dose Compared with Sorafenib 800 mg Initial Dose on Survival in Patients with Advanced and Intermediate Stage Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
- Nomor Panggil T21339fk
![cover](./lib/minigalnano/createthumb.php?filename=images%2Fdocs%2Fcover_potensi-ekspresi-programmed-death-ligand-1-pd-l1-pada-tumor-sel-germ-20231113123956.jpg&width=120)
Tesis
Potensi Ekspresi Programmed Death Ligand-1 (PD-L1) pada Tumor Sel Germinal Ovarium Maligna (TSGOM) sebagai Faktor Prognostik
2019 | BY Fadhlina Muharmi Harahap - Hartono Tjahjadi - Kusmardi- The Potential of Programmed Death Ligand-1 (PD-L1) Expression in Malignant Ovarian Germ Cell Tumor as Prognostic Factor.
- Nomor Panggil T19088fk